TRACON Pharmaceutical (TCON) Misses Q1 EPS by 127c
Tweet
Share
E-mailGet Alerts TCON Hot Sheet
Join SI Premium – FREE
TRACON Pharmaceutical (NASDAQ: TCON) reported Q1 EPS of ($1.33), $1.27 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $100 thousand.
For earnings history and earnings-related data on TRACON Pharmaceutical (TCON) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
